Influence of L-arginine, aminoguanidine, and NG-nitro-L-arginine methyl ester (L-name) on the survival rate in a rat model of hemorrhagic shock.

Nitric oxide (NO) has been implicated in the pathophysiology of hemorrhagic shock. We investigated the influence of L-arginine (the precursor of NO synthesis), N(G)-nitro-L-arginine methyl ester (L-NAME) and aminoguanidine (AG) (inhibitors of NO synthase, with selectivity toward the constitutive and inducible isoforms, respectively) on the survival rate in a rat model of hemorrhagic shock. Anesthetized, male Sprague-Dawley rats (300-350 g) were subjected to hemorrhagic shock for 30 min followed by intravenous injection (1 mL/kg) with normal saline, L-arginine (30 mg/kg), L-NAME (10 mg/kg), L-NAME+L-arginine, AG (1, 10, 100 mg/kg) or AG (100 mg/kg)+L-arginine (n = 5 per group). Hemorrhagic shocked rats treated with saline died within 90 min. In contrast, L-NAME increased the survival time to >72 h in shocked rats. AG (1, 10, and 100 mg/kg) increased the survival time of shocked animals to 150 min, 230 min, and >72 h, respectively. Shocked rats treated with L-arginine died within 80 min, and those that received L-NAME+L-arginine and AG+L-arginine died within 120 min and 110 min, respectively. L-NAME and AG (dose dependently) reduced macroscopic and microscopic injuries, nitrate/nitrite, PGE2 and creatinine production, and inhibited GOT activity in shocked animals. L-arginine reversed the beneficial effects of AG and L-NAME, suggesting the involvement of NO in the pathophysiology of hemorrhagic shock.